RhumbLine Advisers’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35K | Hold |
175
| – | – | ﹤0.01% | 4019 |
|
|
2025
Q1 | $1.04K | Hold |
175
| – | – | ﹤0.01% | 4029 |
|
|
2024
Q4 | $2.33K | Hold |
175
| – | – | ﹤0.01% | 4029 |
|
|
2024
Q3 | $1.42K | Sell |
175
-507
| -74% | -$4.12K | ﹤0.01% | 4077 |
|
|
2024
Q2 | $5.8K | Sell |
682
-5,221
| -88% | -$44.4K | ﹤0.01% | 4060 |
|
|
2024
Q1 | $102K | Buy |
5,903
+86
| +1% | +$1.49K | ﹤0.01% | 3441 |
|
|
2023
Q4 | $74.6K | Sell |
5,817
-2
| -0% | -$26 | ﹤0.01% | 3540 |
|
|
2023
Q3 | $215K | Buy |
5,819
+108
| +2% | +$4K | ﹤0.01% | 3123 |
|
|
2023
Q2 | $230K | Sell |
5,711
-184
| -3% | -$7.41K | ﹤0.01% | 3168 |
|
|
2023
Q1 | $427K | Buy |
5,895
+173
| +3% | +$12.5K | ﹤0.01% | 2492 |
|
|
2022
Q4 | $469K | Buy |
5,722
+54
| +1% | +$4.43K | ﹤0.01% | 2492 |
|
|
2022
Q3 | $536K | Buy |
5,668
+101
| +2% | +$9.55K | ﹤0.01% | 2468 |
|
|
2022
Q2 | $1.08M | Buy |
5,567
+793
| +17% | +$154K | ﹤0.01% | 2098 |
|
|
2022
Q1 | $1.11M | Sell |
4,774
-350
| -7% | -$81.3K | ﹤0.01% | 2092 |
|
|
2021
Q4 | $2.02M | Buy |
5,124
+83
| +2% | +$32.7K | ﹤0.01% | 1878 |
|
|
2021
Q3 | $2.26M | Sell |
5,041
-40
| -0.8% | -$17.9K | ﹤0.01% | 1845 |
|
|
2021
Q2 | $1.98M | Buy |
5,081
+436
| +9% | +$169K | ﹤0.01% | 1954 |
|
|
2021
Q1 | $1.67M | Sell |
4,645
-257
| -5% | -$92.3K | ﹤0.01% | 1989 |
|
|
2020
Q4 | $2.41M | Buy |
4,902
+615
| +14% | +$302K | ﹤0.01% | 1763 |
|
|
2020
Q3 | $1.39M | Buy |
4,287
+42
| +1% | +$13.6K | ﹤0.01% | 1866 |
|
|
2020
Q2 | $1.55M | Buy |
4,245
+1,295
| +44% | +$472K | ﹤0.01% | 1866 |
|
|
2020
Q1 | $628K | Buy |
2,950
+161
| +6% | +$34.3K | ﹤0.01% | 2071 |
|
|
2019
Q4 | $1.15M | Buy |
2,789
+66
| +2% | +$27.2K | ﹤0.01% | 2016 |
|
|
2019
Q3 | $961K | Buy |
2,723
+254
| +10% | +$89.6K | ﹤0.01% | 2049 |
|
|
2019
Q2 | $1.24M | Buy |
2,469
+261
| +12% | +$131K | ﹤0.01% | 1973 |
|
|
2019
Q1 | $2.19M | Sell |
2,208
-44
| -2% | -$43.7K | ﹤0.01% | 1653 |
|
|
2018
Q4 | $1.96M | Buy |
2,252
+762
| +51% | +$662K | ﹤0.01% | 1655 |
|
|
2018
Q3 | $1.54M | Sell |
1,490
-80
| -5% | -$82.7K | ﹤0.01% | 1801 |
|
|
2018
Q2 | $1.44M | Buy |
1,570
+227
| +17% | +$208K | ﹤0.01% | 1850 |
|
|
2018
Q1 | $1.31M | Buy |
1,343
+255
| +23% | +$249K | ﹤0.01% | 1825 |
|
|
2017
Q4 | $492K | Sell |
1,088
-176
| -14% | -$79.6K | ﹤0.01% | 2234 |
|
|
2017
Q3 | $523K | Buy |
1,264
+9
| +0.7% | +$3.72K | ﹤0.01% | 2287 |
|
|
2017
Q2 | $439K | Buy |
1,255
+127
| +11% | +$44.4K | ﹤0.01% | 2368 |
|
|
2017
Q1 | $579K | Buy |
1,128
+34
| +3% | +$17.5K | ﹤0.01% | 2184 |
|
|
2016
Q4 | $388K | Sell |
1,094
-12
| -1% | -$4.26K | ﹤0.01% | 2356 |
|
|
2016
Q3 | $592K | Buy |
1,106
+40
| +4% | +$21.4K | ﹤0.01% | 2099 |
|
|
2016
Q2 | $600K | Buy |
1,066
+374
| +54% | +$211K | ﹤0.01% | 2087 |
|
|
2016
Q1 | $329K | Sell |
692
-3
| -0.4% | -$1.43K | ﹤0.01% | 2482 |
|
|
2015
Q4 | $459K | Buy |
695
+134
| +24% | +$88.5K | ﹤0.01% | 2296 |
|
|
2015
Q3 | $441K | Buy |
561
+65
| +13% | +$51.1K | ﹤0.01% | 2317 |
|
|
2015
Q2 | $654K | Buy |
+496
| New | +$654K | ﹤0.01% | 2151 |
|